Africaled

Cape Town — An African-led effort to develop an HIV vaccine has launched a clinical trial at the Desmond Tutu Health Foundation in Cape Town, organizers announced, with the first participant already enrolled. The study, called BRILLIANT 011 and led by The BRILLIANT Consortium, is being conducted by the South African Medical Research Council (SAMRC) and is designed to target the strains of HIV that are circulating in Southern Africa. "The trial is...marking a major milestone in African-led HIV vaccine research. BRILLIANT…